An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

Weight loss injections boost the glucagon-like peptide-1 (GLP-1) hormone, which is a naturally produced hormone in the ...

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...

With the growing popularity of weight loss medications, many people are turning to prescription options to help them achieve their health goals. Medications like Ozempic, Mounjaro, and Wegovy are ...

Mangoceuticals Inc. (NASDAQ:MGRX) is on a mission to rewrite the playbook for men’s performance, health, and vitality. Its pursuit comes at a time when opportunities have become enormous, with patent ...

Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Novo Nordisk now has an Ozempic pill. Citing a Novo spokesperson, pharmaceuticals news site BioPharmaDive reported yesterday ...

Plus, salon owners are seeing a massive drawdown in clients coming in for their regular scheduled appointments, citing ...